Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 1035-1037

  Ritter, M M ^a   Frilling, A ^b   Crossey, P A ^d   Hoppner W ^c   Maher, E R ^d   Mulligan, L ^e,f   Ponder, B A J ^e   Engelhardt, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; PEDIGREE; PHEOCHROMOCYTOMA; POINT MUTATION; PRIORITY JOURNAL; SIPPLE SYNDROME; SYNDROME; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; FEMALE; GENE REARRANGEMENT; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PEDIGREE; PHEOCHROMOCYTOMA; PREGNANCY; VARIATION (GENETICS);

EID: 0029864421     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.3.1035     Document Type: Article

References (22)

1. Levine C, Skimming J, Levine E. 1992 Familial pheochromocytomas with unusual associations. J Pediatr Surg. 27:447-451.
2. Neumann HPH, Berger DP, Sigmund G, et al. 1993 Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med. 329:1531-1538.
3. May AG, Moss A, Gutierrez OH, Burday SZ, Campbell RG. 1981 Clinical study of pheochromocytoma. Am J Surg. 141:346-352.
4. Steiner AL, Goodman AD, Powers SR. 1968 Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine. 47:371-409.
5. Jacob K, Vogt W, Schwertfeger G. 1984 Sensitive mass fragmentographic determination of acidic catecholamine metabolites in human body fluids. J Chromatogr. 290:331-337.
6. Wells SA, Baylin SB, Lineham WM, Farrell RE, Cox EB, Cooper CW. 1978 Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg. 188:139-141.
7. Kempter B, Ritter MM. 1991 Unexpected high calcitonin concentrations after pentagastrin stimulation. Clin Chem. 37:473.
8. Mathew CGP, Chin KS, Easton DF, et al. 1987 A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature. 328:527-528.
9. Crossey PA, Richards FM, Foster K, et al. 1994 Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet. 3:1303-1308.
10. Latif F, Tory K, Gnarra J, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317-1320.
11. Gagel RF, Tashjian AH, Cummings T, et al. 1988 The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med. 318:478-484.
12. Gibson WGH, Peng T, Croker BP. 1982 Age-associated C-cell hyperplasia in the human thyroid. Am J Pathol. 106:388-393.
13. Lips CJM, Landsvater RM, Höppener JWM, et al. 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 331:828-835.
14. Donis-Keller H, Dou S, Chi D, et al. 1993 Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 2:851-856.
15. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458-460.
16. Mulligan LM, Eng C, Healey CS, et al. 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6:70-74.
17. Hofstra RMW, Landsvater RM, Ceccherini I, et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:375-376.
18. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 10:509-513.
19. Glenn GM, Daniel LN, Choyke P, et al. 1991 Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet. 87:207-210.
20. Tisherman SE, Tisherman BG, Tisherman SA, Dunmire S, Levey GS, Mulvihill JJ. 1993 Three-decade investigation of familial pheochromocytoma? An allele of von Hippel-Lindau disease? Arch Intern Med. 153:2550-2556.
21. Chen F, Kishida T, Yao M, et al. 1995 Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat. 5:66-75.
22. Maher ER, Yates JRW, Harries R, et al. 1990 Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 77:1151-1163.